• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Metabolic Endocrinology - Type II Diabetes Drug Pipeline Report Product Image

Metabolic Endocrinology - Type II Diabetes Drug Pipeline Report

  • Published: June 2007
  • 26 pages
  • Life Science Analytics

Life Science Analytics, "Metabolic Endocrinology - Type II Diabetes Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of type ii diabetes drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of READ MORE >

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Type II Diabetes Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects



--Top Companies in late stage Type II Diabetes Projects
--Astellas Pharma Inc
--Akesis Pharmaceuticals Inc
--Bristol-Myers Squibb Company
--AstraZeneca Plc
--Dr Reddys Laboratories Ltd
--ConjuChem Inc.
--GlaxoSmithKline plc
--Genfit
--Kissei Pharmaceutical Co., Ltd.
--Johnson & Johnson
--Mitsubishi Tanabe Pharma Corporation
--Metabolex, Inc.
--Novo-Nordisk A/S
--Novartis AG
--Pfizer Inc
--Ortho-McNeil, Inc.
--Sanofi-Aventis
--Roche Holdings Ltd
--Teva Pharmaceutical Industries Ltd
--Takeda Pharmaceutical Company Limited

--Top Companies in early stage Type II Diabetes Projects
--Allergan Inc
--Akesis Pharmaceuticals Inc
--Arisaph Pharmaceuticals, Inc.
--Amgen Inc
--Bristol-Myers Squibb Company
--Biovitrum AB
--Diabetology Ltd
--DARA BioSciences, Inc.
--DiaMedica Inc.
--DiaKine Therapeutics, Inc.
--Genzyme Corporation
--Eli Lilly & Co
--Pfizer Inc
--Innodia Inc.
--Roche Holdings Ltd
--Protemix Corporation Limited
--SCOLR Pharma Inc
--Sanofi-Aventis
--TransTech Pharma, Inc.
--Theracos, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos